Cargando…
Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Efficacy of Statins in apoE(−/−) C57BL/6 Mice
Previously, we found that exogenous ganglioside GM3 had an antiatherosclerotic efficacy and that its antiatherosclerotic efficacy could be enhanced by reconstituted high-density lipoprotein (rHDL). In this study, we hypothesized that GM3-functionalized rHDL (i.e., GM3-rHDL) as a nanocarrier can prom...
Autores principales: | Wei, Bo, Li, Yuanfang, Ao, Meiying, Shao, Wenxiang, Wang, Kun, Rong, Tong, Zhou, Yun, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698139/ https://www.ncbi.nlm.nih.gov/pubmed/36432725 http://dx.doi.org/10.3390/pharmaceutics14112534 |
Ejemplares similares
-
Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein
por: Rong, Tong, et al.
Publicado: (2021) -
Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
por: Fernández-de-Retana, Sofía, et al.
Publicado: (2017) -
Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011) -
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)